Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant - PA: Nutrition, Metabolism and Diabetes

Université Laval

$100,000.00

Molecular characterization of the Na-K-Cl cotransporter 2 (NKCC2) splice variants in the thick ascending loop of Henle

EF 2021-22

Résumé
NKCC2 operates with other transporters in the kidney to reabsorb or excrete salt and water in appropriate quantities. Importantly, high blood pressure (or hypertension) is known to develop when the kidney retains excessive amounts of salts and low sodium concentration (or hyponatremia) in the body when the kidney retains excessive amount of water. Hypertension is a major risk factor for cardiovascular diseases and hyponatremia can be deleterious to neurons in the brain. To date, three main types of NKCC2 have been identified in the kidney. Those that are of interest to us are called "A", "F" and "B". Interestingly, these different types (or variants) are not present in the exact same locations in the kidney and they appear to assume different functions. For instance, "A" could be more important in controlling water reabsorption/excretion, "F" in controlling salt reabsorption/excretion and "B" in controlling renal blood circulation. Diuretics such as Lasix (which are used in the treatment of fluid overload, certain forms of hypertension and hyponatremia) exert their effect by blocking NKCC2, but they act on all three variants indiscriminately and cause several side-effects for this reason. We believe that great benefits could be derived from the inhibition of a single variant at a time not only to improve drug tolerance, but also to obtain more precise effects. For instance, blocking "A" could be useful in preventing water retention, "F" in preventing salt retention and "B" in improving renal blood circulation. The purpose of this proposal is to study: 1) the role of each variant in great detail through animal models in which only one of the variants is missing and 2) the structure of these variants to determine whether certain regions could be targeted by specific drugs eventually. A refined knowledge of how NKCC2 works in the kidney could lead to the identification of well-tolerated interventions to halt the progression of many clinical disorders.
Programme
Project Grant - PA: Nutrition, Metabolism and Diabetes
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
456703
Name
Isenring Paul
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Cell and Developmental Physiology
Projecttitle
Molecular characterization of the Na-K-Cl cotransporter 2 (NKCC2) splice variants in the thick ascending loop of Henle
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Nutrition, Metabolism and Diabetes
Keyworddelim
Acute Tubular Necrosis; Blood Pressure Control; Chronic Renal Failure; Diuretics; Mutational Analyses; Na-K-Cl Cotransporters; Nkcc2 And Splice Variants; Renal Physiology; Tubuloglomerular Feedback; Water Balance
Abstract
NKCC2 operates with other transporters in the kidney to reabsorb or excrete salt and water in appropriate quantities. Importantly, high blood pressure (or hypertension) is known to develop when the kidney retains excessive amounts of salts and low sodium concentration (or hyponatremia) in the body when the kidney retains excessive amount of water. Hypertension is a major risk factor for cardiovascular diseases and hyponatremia can be deleterious to neurons in the brain. To date, three main types of NKCC2 have been identified in the kidney. Those that are of interest to us are called "A", "F" and "B". Interestingly, these different types (or variants) are not present in the exact same locations in the kidney and they appear to assume different functions. For instance, "A" could be more important in controlling water reabsorption/excretion, "F" in controlling salt reabsorption/excretion and "B" in controlling renal blood circulation. Diuretics such as Lasix (which are used in the treatment of fluid overload, certain forms of hypertension and hyponatremia) exert their effect by blocking NKCC2, but they act on all three variants indiscriminately and cause several side-effects for this reason. We believe that great benefits could be derived from the inhibition of a single variant at a time not only to improve drug tolerance, but also to obtain more precise effects. For instance, blocking "A" could be useful in preventing water retention, "F" in preventing salt retention and "B" in improving renal blood circulation. The purpose of this proposal is to study: 1) the role of each variant in great detail through animal models in which only one of the variants is missing and 2) the structure of these variants to determine whether certain regions could be targeted by specific drugs eventually. A refined knowledge of how NKCC2 works in the kidney could lead to the identification of well-tolerated interventions to halt the progression of many clinical disorders.
Competitiondate
202109
Approvedterm2
1 yr 0 mth
Pinamesdelim
Isenring, Paul
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~